Menu
GeneBe

2-166068945-T-C

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001165963.4(SCN1A):c.264+4413A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.075 in 152,228 control chromosomes in the GnomAD database, including 1,149 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.075 ( 1149 hom., cov: 33)

Consequence

SCN1A
NM_001165963.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.28
Variant links:
Genes affected
SCN1A (HGNC:10585): (sodium voltage-gated channel alpha subunit 1) Voltage-dependent sodium channels are heteromeric complexes that regulate sodium exchange between intracellular and extracellular spaces and are essential for the generation and propagation of action potentials in muscle cells and neurons. Each sodium channel is composed of a large pore-forming, glycosylated alpha subunit and two smaller beta subunits. This gene encodes a sodium channel alpha subunit, which has four homologous domains, each of which contains six transmembrane regions. Allelic variants of this gene are associated with generalized epilepsy with febrile seizures and epileptic encephalopathy. Alternative splicing results in multiple transcript variants. The RefSeq Project has decided to create four representative RefSeq records. Three of the transcript variants are supported by experimental evidence and the fourth contains alternate 5' untranslated exons, the exact combination of which have not been experimentally confirmed for the full-length transcript. [provided by RefSeq, Oct 2015]
SCN1A-AS1 (HGNC:54069): (SCN1A and SCN9A antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.228 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SCN1ANM_001165963.4 linkuse as main transcriptc.264+4413A>G intron_variant ENST00000674923.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SCN1AENST00000674923.1 linkuse as main transcriptc.264+4413A>G intron_variant NM_001165963.4 P4P35498-1
SCN1A-AS1ENST00000651574.1 linkuse as main transcriptn.488-6343T>C intron_variant, non_coding_transcript_variant

Frequencies

GnomAD3 genomes
AF:
0.0749
AC:
11396
AN:
152110
Hom.:
1147
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.232
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0380
Gnomad ASJ
AF:
0.0167
Gnomad EAS
AF:
0.0185
Gnomad SAS
AF:
0.0245
Gnomad FIN
AF:
0.00772
Gnomad MID
AF:
0.0665
Gnomad NFE
AF:
0.0105
Gnomad OTH
AF:
0.0526
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0750
AC:
11418
AN:
152228
Hom.:
1149
Cov.:
33
AF XY:
0.0723
AC XY:
5385
AN XY:
74450
show subpopulations
Gnomad4 AFR
AF:
0.232
Gnomad4 AMR
AF:
0.0378
Gnomad4 ASJ
AF:
0.0167
Gnomad4 EAS
AF:
0.0185
Gnomad4 SAS
AF:
0.0245
Gnomad4 FIN
AF:
0.00772
Gnomad4 NFE
AF:
0.0105
Gnomad4 OTH
AF:
0.0520
Alfa
AF:
0.0426
Hom.:
72
Bravo
AF:
0.0852
Asia WGS
AF:
0.0430
AC:
150
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.52
Cadd
Benign
14
Dann
Benign
0.64

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs10497279; hg19: chr2-166925455; API